# Safety and Immunogenicity of COVID-19 Vaccine, Inactivated in Healthy Population Aged From 3 to 11 Years

> **NCT05137418** · PHASE3 · COMPLETED · sponsor: **Sinovac Research and Development Co., Ltd.** · enrollment: 1000 (actual)

## Conditions studied

- COVID-19

## Interventions

- **BIOLOGICAL:** COVID-19 Vaccine,Inactivated

## Key facts

- **NCT ID:** NCT05137418
- **Lead sponsor:** Sinovac Research and Development Co., Ltd.
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2021-11-27
- **Primary completion:** 2023-01-27
- **Final completion:** 2023-01-27
- **Target enrollment:** 1000 (ACTUAL)
- **Last updated:** 2023-10-16


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05137418

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05137418, "Safety and Immunogenicity of COVID-19 Vaccine, Inactivated in Healthy Population Aged From 3 to 11 Years". Retrieved via AI Analytics 2026-07-19 from https://api.ai-analytics.org/clinical/NCT05137418. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*